Bio-Gene Technology Limited

ASX (AUD): Bio-Gene Technology Limited (BGT)

Last Price

0.052

Today's Change

-0.001 (1.88%)

Day's Change

0.05 - 0.065

Trading Volume

4,844,796

Overview

Market Cap

10 Million

Shares Outstanding

201 Million

Avg Volume

433,794

Avg Price (50 Days)

0.04

Avg Price (200 Days)

0.05

PE Ratio

-5.20

EPS

-0.01

Earnings Announcement

24-Feb-2025

Previous Close

0.05

Open

0.06

Day's Range

0.05 - 0.065

Year Range

0.028 - 0.085

Trading Volume

4,844,796

Price Change Highlight

1 Day Change

-1.89%

5 Day Change

62.50%

1 Month Change

20.93%

3 Month Change

-10.34%

6 Month Change

20.93%

Ytd Change

20.93%

1 Year Change

-13.33%

3 Year Change

-77.39%

5 Year Change

-72.63%

10 Year Change

-74.00%

Max Change

-74.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Bio-Gene Technology Limited, an agtech development company, engages in developing and commercializing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a beta-triketone insecticide product; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University for the development of a tissue culture system to support the expansion of tree plantations and scale-up of future Qcide oil production. It also has research collaborations with BASF, Grains Research and Development Corporation, and Queensland Department of Agriculture and Fisheries for assessing activity against grain storage pests. Bio-Gene Technology Limited was incorporated in 1995 and is based in Melbourne, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment